Medistep Healthcare, a growing player in India’s pharmaceutical and healthcare products sector, has launched its initial public offering (IPO) to support expansion and strengthen operations. The company specialises in trading and manufacturing a diverse portfolio, including pharmaceutical formulations, intimate care and hygiene products, surgical items, and nutraceuticals.
The proceeds from the public issue will be used to fund capital expenditure for plant and machinery at its existing manufacturing facility, boost working capital, and meet general corporate requirements. This investment aims to scale up production capacity, enhance product quality, and meet rising demand in both domestic and international markets.
Medistep Healthcare’s focus on intimate care and nutraceutical manufacturing positions it within fast-growing healthcare segments driven by increasing consumer awareness and preventive health trends. By expanding capabilities, the company plans to address evolving healthcare needs and improve accessibility to quality products.
While the IPO opened on August 8 and closes on August 12, market interest has been strong, with robust subscription levels and a positive grey market premium suggesting healthy investor confidence. The listing on NSE SME is expected on August 18.